Indian billionaire investor Rakesh Jhunjhunwala says he's very upbeat about his country's growth potential after the country underwent a massive banking crisis and the rollout...Asia Economyread more
There's more pain ahead for the U.S. and China amid their bilateral trade dispute, according to one expert.China Politicsread more
Alphabet Inc's Google said Tuesday that keeping phones up to date and secure was in "everyone's best interests," shortly after the U.S. temporarily eased some trade...Technologyread more
You know there's an underlying problem when investment firms start to cut exposure to a particular asset class.Commentaryread more
The issue of corporate debt has surfaced as companies continue to use the low rates the Fed has provided to lever up their balance sheets.The Fedread more
Stocks in Asia were mostly higher on Tuesday as a temporary reprieve in U.S.-China trade tensions provided a breather.Asia Marketsread more
A record 257.4 million travelers are expected to opt for U.S. airlines for travel this summer, the 10th consecutive annual increase, a trade group forecast on Tuesday.Airlinesread more
Huya, a Chinese live streaming platform focused on gaming, is looking to expand into the U.S. in the next couple of years, CEO Rongjie Dong told CNBC. The U.S. is expected to...Technologyread more
Most U.S. hedge funds aren't expecting another big stock market sell-off as more firms curb bets on volatility, according to Nomura.Marketsread more
Mall owners are increasingly building out food halls with local chef-driven eateries, sushi bars and premium coffee shops.Retailread more
While Trump's lawyers had argued that the committee's subpoena did not have a legitimate legislative purpose — and was therefore invalid — Mehta took a broader view.Politicsread more
President-elect Donald Trump met with the chief executives of German chemical giant Bayer and agriculture company Monsanto last week and discussed commitments to the U.S. following their planned $66 billion merger. The Trump team says as a result of the meeting, the companies made new pledges for jobs and research spending in the U.S.
Analysts say not so fast.
In a call with reporters Tuesday, transition team spokesman Sean Spicer said Bayer and Monsanto committed to $8 billion in new R&D spending in the U.S., as well as to retain 100 percent of Monsanto's U.S. workforce, create 3,000 new U.S. high-tech jobs and to keep Monsanto's headquarters in St. Louis. None of this, Spicer said, had been in the works previously.
Some of that has analysts scratching their heads. When the companies announced the proposed deal in September, they said the combined agriculture business would have its global Seeds & Traits and North American commercial headquarters in St. Louis.
"St. Louis to remain the headquarters of the North American seeds business has been the plan from the start," Bernstein analyst Jeremy Redenius said Tuesday in a telephone interview.
The research spending, as well, doesn't appear new, Redenius said. Bayer and Monsanto said in a joint statement after Spicer's remarks that the "combined company expects to spend approximately $16 billion in R&D in agriculture over the next six years with at least half of this investment made in the United States."
That amounts to about $2.7 billion a year, which roughly equates to what the combined companies already spend in that area globally, Redenius said. As for the U.S. breakdown, he estimates it's likely close to half already; Monsanto spends $1.5 billion a year, the majority of which is in the U.S., he said, and Bayer already invests in R&D here as well.
"Not an increase, but not substantially cutting," he said of the global figure.
"This is an investment in innovation and people that will create several thousand new high-tech, well-paying jobs after integration is complete, jobs that will keep America at the forefront of agricultural innovation and that serve U.S. farmers by delivering better products and services faster," Bayer CEO Werner Baumann and Monsanto CEO Hugh Grant said in their joint statement.
The companies said in September they expect the deal to close by the end of 2017, subject to regulatory approvals. Redenius projects closing could stretch into 2018 as another proposed merger in the industry — Dow and DuPont — is still awaiting European approval.
Bayer and Monsanto said in September they planned about $1.5 billion in "annual synergies" three years after the merger is completed — synergies being code for cost-cuts — and didn't announce any planned changes to that this week.
"The thing the U.S. government is concerned about is jobs," Bernstein analyst Ronny Gal said Tuesday. "They didn't say, 'We're not going to lay off people,' which they will; what they're really saying is: 'We are going to commit to spend a certain amount of money on U.S.-based research.' "
Would they have done that anyway?
"Some of it," Gal said. "For sure."